Nanobusiness News

RSS
Integran Announces Issuance of US Patent for Unique Metal-Polymer Hybrid Components

Integran Announces Issuance of US Patent for Unique Metal-Polymer Hybrid Components

ESI Strengthens Laser-Based Wafer Processing Capabilities Through GSI Semiconductor Systems Business Acquisition

ESI Strengthens Laser-Based Wafer Processing Capabilities Through GSI Semiconductor Systems Business Acquisition

Tekmira's Collaboration Partner, NCI Presents Preclinical Results of Nanoparticle-Based Combinatorial siRNA Therapy

Tekmira's Collaboration Partner, NCI Presents Preclinical Results of Nanoparticle-Based Combinatorial siRNA Therapy

Winbond Electronics Increases Production of 58-nm Multi-I/O SpiFlash Memories

Winbond Electronics Increases Production of 58-nm Multi-I/O SpiFlash Memories

BIND Therapeutics Announces Positive Phase 1 Clinical Data for Nanomedicine, BIND-014

BIND Therapeutics Announces Positive Phase 1 Clinical Data for Nanomedicine, BIND-014

Artificial Micro-Fiber Spider Web for Pest Control

Artificial Micro-Fiber Spider Web for Pest Control

Fujitsu Semiconductor Mass Produces 2G/3G/4G Baseband Processors Using Synopsysf 28-nm MIPI M-PHY

Fujitsu Semiconductor Mass Produces 2G/3G/4G Baseband Processors Using Synopsysf 28-nm MIPI M-PHY

Nanochemical Center of Peking University Signs Research Collaboration with NANOTEC Thailand

Nanochemical Center of Peking University Signs Research Collaboration with NANOTEC Thailand

mPhase Seeks Licensing Opportunities for Nanotechnology-Inspired Drug Delivery System

mPhase Seeks Licensing Opportunities for Nanotechnology-Inspired Drug Delivery System

Tekmira Announces Phase I Results of Lipid Nanoparticle-Based TKM-PLK1 RNAi Therapeutic

Tekmira Announces Phase I Results of Lipid Nanoparticle-Based TKM-PLK1 RNAi Therapeutic

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.